Algernon Pharmaceuticals Inc (AGNPF)

[ILuvblo2]

Looks like they may start to give us some more info....(a lot more shared in this monthly then in blos)

During the month of July 2018, the Company continued optimizing and improving the components of the FAIMS Point of Care (“POC”) prototype device, namely the ionization source and FAIMS waveform generator. The R&D Team plans to further develop the device, as well as implement findings from ongoing research conducted on biomarkers found in the breath that are associated with diseases. The Company also continues to evaluate the potential commercial impact of an assortment of biomarkers tested so far to determine the most effective strategy going forward.